StonvexLoading…
StonvexStonvexStonvexCore line items from HSAI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $432.94M | $284.57M | $264.37M | $174.37M |
Operating Income | $24.13M | $-28.07M | $-80.51M | $-54.84M |
Net Income | $62.33M | $-14.03M | $-67.04M | $-43.61M |
EPS (Diluted) | $0.43 | $-0.11 | $-0.54 | $-0.94 |
Total Assets | $1.61B | $820.57M | $797.55M | $556.66M |
Total Liabilities | $329.26M | $281.93M | $253.56M | $144.65M |
Cash & Equivalents | $237.88M | $388.94M | $218.96M | $132.41M |
Free Cash Flow OCF − CapEx | $-27.51M | $-26.86M | $-49.22M | $-134.44M |
Shares Outstanding | 146.44M | 129.19M | 124.78M | 115.53M |